“Patient Zero Comes Back From Stage Four Cancer: Was It Ivermectin?”

Drs. Paul Marik and Kathleen Ruddy are exploring a new frontier in cancer treatment

John Leake

Feb 26, 2024

While researching our book, The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex, I interviewed several people in different parts of the country who told me iterations of the same deeply disturbing story. While a much-loved family member languished in hospital with COVID-19—increasingly struggling to breathe, his or her blood oxygen level dropping—the hospital steadfastly refused to allow the sick patient to try ivermectin.

Even when doctors acknowledged that the patient was NOT getting better with existing care and would probably soon require mechanical ventilation, the hospital still absolutely refused to allow a family physician to enter the hospital to administer ivermectin—an FDA-approved drug, taken by hundreds of millions every year for parasitical diseases in the tropics.

Some of the stories were almost beyond belief. Even after the family retained an attorney who succeeded in obtaining a court order for ivermectin to be administered, the hospital deployed attorneys to challenge the court order instead of simply giving the poor patient ivermectin.

Many of these patients ultimately did receive ivermectin, and some of their recovery stories were downright miraculous. Within 24 hours of receiving the first dose they started to improve. We now know that Ivermectin works by counteracting Hemagglutination caused by the SARS-CoV-2 spike protein, thereby breaking up micro blood clots that impede respiratory function.

At the time I heard these horror stories of hospitals resembling something out of a Stephen King novel, I wondered if it was possible that Ivermectin had other bio-chemical properties that could be useful for impeding other pathological processes. Generally speaking, the natural compound struck me as marvelous.

I was therefore pleased to learn that Dr. Paul Marik and his colleague, Dr. Kathleen Ruddy, have been studying the possible benefit of Ivermectin for the treatment of cancer. A few weeks ago, I called Dr. Marik to discuss a dear friend in Dallas who has cancer. His message was clear: My friend should definitely talk to her doctor about trying ivermectin, mebendazole, and other repurposed drugs. They are perfectly safe, inexpensive, have none of the ghastly side effects of conventional chemotherapy, and there is strong and increasingly evidence that they are effective against cancer.

This morning I woke up to a story published by the fine investigative journalist Mary Beth Pfeiffer headlined Patient Zero Comes Back From Stage Four Cancer: Was It Ivermectin. I highly recommend reading it.

Share


Posted

in

by

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *